Search clinical trials for: Buprenorphine transdermal delivery system

Total 1274 results

Edwards Lifesciences

Completed

PREVAIL-TF: Transfemoral Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)

Aortic Valve Stenosis

Germany, France, United Kingdom, Belgium
Cerenovus, Part of DePuy Synthes Products, Inc.

Terminated

Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

Intracranial Aneurysm

United States
Bolton Medical

Completed

Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms

Abdominal Aortic Aneurysms

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Institute... and other collaborators

Completed

Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever

Hemorrhagic Fever With Renal Syndrome

United States
Centre Antoine Lacassagne

Recruiting

Conventional Oxygen Therapy Versus Continuous Transnasal High Flow Oxygen Therapy for Head and Neck Diagnostic Panendoscopy Under General Anesthesia in Spontaneous Ventilation (OPTINOSE)

Head and Neck Cancer

France
Titan Pharmaceuticals
National Institute on Drug Abuse (NIDA)

Completed

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

Opioid Dependency

United States
Abbott Medical Devices

Active, not recruiting

Portico NG Approval Study

Symptomatic Severe Aortic Stenosis

United States, Australia, Denmark, Italy, United Kingdom
Prisma Health-Upstate
Clemson University

Recruiting

CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine

Opioid-use Disorder

United States
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

Opioid Use Disorder
Thomas Jefferson University
National Institute on Drug Abuse (NIDA)

Completed

Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome

United States
Ruth M. Rothstein CORE Center
Health Resources and Services Administration (HRSA); The New York Academy of...

Completed

The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration (BUP)

HIV Infections | Post-Traumatic Stress Disorders | Opiate Dependence | AIDS

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders

United States
Cryopraxis Criobiologia Ltda.
Hospital Federal de Bonsucesso

Unknown

Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid (LipAge)

Lipodystrophies | Aesthetics Procedure

Brazil
Polares Medical SA
Polares Medical, Inc.

Not yet recruiting

EXPLORE FMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Functional Mitral Regurgitation

Functional Mitral Regurgitation
NeoChord

Recruiting

Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System (AcChord)

Heart Valve Diseases | Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Prolapse | Mitral Valve Disease

Germany, Greece, Switzerland
Women's Hospital HUS

Enrolling by invitation

How Well do the Current Cesarean Deliveries Adhere to the Published ERAS Guidelines?

Cesarean Section Complications

Finland
Renishaw
Herantis Pharma Plc.

Active, not recruiting

Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions

Brain Diseases | Nervous System Diseases | Parkinson Disease | Movement Disorders | Neuro-Degenerative Disease

Finland, Sweden
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy (PRELUDE)

Macular Degeneration | Geographic Atrophy | Visual Acuity

United States
BioDelivery Sciences International

Completed

Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film

Pain

United States
Medical University of Vienna

Completed

Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study (MYSTAR)

Myocardial Infarction

Austria
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Teva Pharmaceuticals USA

Withdrawn

An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.

Evaluation of QTc Interval
Yale University
National Institute on Drug Abuse (NIDA)

Completed

HIV Risk Reduction and Drug Abuse Treatment in Malaysia

Opiate Dependence

United States, Malaysia
University of Bristol
Royal United Hospitals Bath NHS Foundation Trust

Recruiting

CHIEF PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease) (CHIEF PD)

Parkinson Disease

United Kingdom
NovoStent Corporation

Unknown

SAMBA EU Femoropopliteal Trial

Peripheral Vascular Disease

Germany
Grünenthal GmbH

Terminated

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations

Healthy

Germany
Senthil Sadhasivam
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute...

Recruiting

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes (Mother/BabyOUD)

Opioid-use Disorder | Opioid Use, Unspecified | Buprenorphine Dependence

United States
BioDelivery Sciences International

Completed

Long-term Open-Label Safety Study to Evaluate EN3409

Osteoarthritis | Low Back Pain | Neuropathic Pain

United States
University of Virginia

Not yet recruiting

Feasibility of Delivering VergeRx at FQHCs

Tobacco Use Cessation

United States
Lifespan
The Miriam Hospital; University of Rhode Island

Active, not recruiting

Medication Maintenance Therapy in Community Pharmacy Settings (MATPharm)

Opioid-use Disorder

United States
Astellas Pharma Global Development, Inc.

Withdrawn

A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Opioid Use Disorder
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
Paolo Mannelli
Alkermes, Inc.

Completed

Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence (BUP/NXT-VIVI)

Opiate Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University of California, San Francisco and other collaborators

Not yet recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Opioid Use Disorder

United States
Janssen Pharmaceutical K.K.

Recruiting

A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer (TAR-210)

Urinary Bladder Neoplasms | Receptors, Fibroblast Growth Factor

Japan
Janssen Research & Development, LLC

Recruiting

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

Urinary Bladder Neoplasms | Receptors, Fibroblast Growth Factor

Korea, Republic of, United States, Germany, Spain, Netherlands
Polares Medical SA
Polares Medical, Inc.

Not yet recruiting

EXPLORE DMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1

Pregnancy | Opiate Dependence

United States
MetroHealth Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV

Cardiovascular Diseases | HIV Infection | Opioid-use Disorder

United States
ZARS Pharma Inc.

Completed

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

Pain | Osteoarthritis, Knee

United States
Fox Chase Cancer Center

Recruiting

Buprenorphine for Cancer Pain

Cancer-Related Pain

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers

Healthy

Belgium
NYU Langone Health
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Opioid Use Disorder (OUD)

United States
Pediatrix

Completed

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

Neonatal Abstinence Syndrome | Neonatal Withdrawal Syndrome

United States
University Hospital, Ghent

Recruiting

Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass (LABOR)

Hypoglycemia | Gastric Outlet Obstruction | Steatohepatitis | Gastric Bypass | Parenteral Support

Belgium
Symetis SA

Terminated

CHANGE Neo™ TA Registry With ACURATE Neo™ Aortic Bioprosthesis and ACURATE Neo™ TA Transapical Delivery System

Aortic Stenosis

Germany
Johns Hopkins University
The New York Academy of Medicine

Completed

Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants

HIV Infections | HIV Seropositivity | Opiate Dependence

United States
Janssen Pharmaceutical K.K.

Completed

A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain

Pain | Cancer

Japan
University of Pennsylvania
National Institute of Drug Abuse; Expertise France

Completed

Medication-assisted Treatment for Injecting Drug Users in Vietnam (OIT-HCMC)

HIV Infections | Opioid Use Disorder

Search clinical trials for: Buprenorphine transdermal delivery system

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations